Results 241 to 250 of about 1,275,927 (291)
Some of the next articles are maybe not open access.
Mucormycosis in the immunocompromised host
Infection, 1983We are presenting two typical case histories of mucormycosis in patients with acute leukaemia which illustrate some of the important features of this infection in compromised hosts. In such patients, mucormycosis is mostly pulmonary or widely disseminated and often has a rapidly fatal course.
S, Bhaduri +3 more
openaire +2 more sources
Fever in Immunocompromised Hosts
Emergency Medicine Clinics of North America, 2013Fever is one of the most common reasons for the emergency department presentation of immunocompromised patients. Their differential diagnosis can be broad and includes rare or unexpected pathogens. Certain infectious causes of fever portend true emergencies; if they are not managed appropriately, rapid progression and death may ensue.
Devang M, Patel, David J, Riedel
openaire +2 more sources
Vaccination of the immunocompromised host
Wiener Medizinische Wochenschrift, 2004Vaccinations are safe and effective in immunocompromised patients. Apparently most vaccines in this patient population are underutilized. General vaccination recommendations are expressed for influenza, diphtheria and tetanus. Pneumococcal, meningococcal und Haemophilus influenzae B immunizations are specially indicated for patients with or developing ...
Andrew J, Ullmann +2 more
openaire +2 more sources
Travel and the immunocompromised host
Hospital Medicine, 2000Increasing opportunities for travel and advances in medicine mean that immunocompromised patients may venture to potentially risky parts of the world. This article examines the risks faced by such travellers. Some limitations of standard travel vaccines are discussed and suggestions are made as to how best to advise such travellers.
openaire +2 more sources
Pneumonia in the immunocompromised host
Current Opinion in Pulmonary Medicine, 2014Novel treatment modalities for previously fatal diseases, including newer chemotherapeutic and biologic agents and the expansion of the indications for solid organ and stem cell transplantation, have resulted in prolonged patient survival and a significant increase in the population of immunocompromised hosts (ICHs).This review discusses the increasing
Alyssa R, Letourneau +2 more
openaire +2 more sources
Madurella infection in an immunocompromised host
International Journal of Dermatology, 2000A 77‐year‐old farmer, born and living in Sardinia, affected by acute myelogenous leukemia and undergoing chemotherapy treatment with cytosine arabinoside, presented at the Institute of Dermatology of Sassari in March 1998 with multiple subcutaneous lesions on the legs (Fig. 1) which had appeared 3 months previously.
SATTA, Rosanna Rita, Sanna S, Cottoni F.
openaire +3 more sources
Sinusitis in the immunocompromised host
Current Infectious Disease Reports, 1999Sinusitis occurs in a wide range of immunocompromised hosts, including neutropenic patients, diabetic patients, patients in critical care units, and patients with HIV infection. Reversal of underlying risk factors, such as neutropenia or diabetic ketoacidosis, is essential in the treatment of fungal rhinosinusitis.
openaire +2 more sources
Management of the Immunocompromised Host
Medical Clinics of North America, 1984This article deals with the management of the immunocompromised host. Mechanisms of immunocompromise include alterations in skin and mucosal barriers, normal oral and intestinal flora, splenic function, and number or function of T cells, B cells, granulocytes, and monocytes.
openaire +2 more sources
Update on Strongyloidiasis in the Immunocompromised Host
Current Infectious Disease Reports, 2010Immunocompromised persons are the most vulnerable population at risk for developing life-threatening clinical syndromes associated with strongyloidiasis, such as hyperinfection syndrome (HS) or dissemination. This review focuses on describing Strongyloides infection in the immunocompromised host, including immune response against this infection ...
María Angélica Terashima Iwashita +2 more
exaly +3 more sources
FEVER IN THE IMMUNOCOMPROMISED HOST
Emergency Medicine Clinics of North America, 1998A broad classification of immune defects provides a framework for the approach to fever in the immunocompromised host. Practical, historical, and physical examination findings are reviewed, and common clinical scenarios are highlighted. A general initial work-up and treatment plan are outlined.
openaire +2 more sources